Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
| Date | Event | Source class |
|---|---|---|
| 1996 | Founded in Genome Valley, Hyderabad | Company history |
| 2016 | ROTAVAC launched in India's national programme | Company history |
| 2018-01 | WHO prequalifies ROTAVAC | Company PR / WHO |
| 2021-01 | DCGI EUA for COVAXIN | Company / regulator history |
| 2021-04 | COVAXIN capacity print of about 700 million doses a year | Company PR |
| 2021-06 | WHO prequalifies ROTAVAC 5D | WHO PQ page |
| 2025-07 | WHO routine inspection of rotavirus lines; four PQ vaccines listed | WHO WHOPIR |
| Asset / print | Capacity or scale | Date and caveat |
|---|---|---|
| ROTAVAC Genome Valley facility | Up to 200 million doses a year | Jan 2018 PQ PR; rotavirus, not the whole plant |
| COVAXIN Hyderabad + Bangalore | About 700 million doses a year | Apr 2021 COVID PR; inactivated viral, historical |
| Portfolio (WHO inspection) | 19 vaccines and 4 biotherapeutics; >125 countries | Jul 2025 WHOPIR |
| Cumulative doses (2021 PR boilerplate) | More than 4 billion doses delivered historically | Apr 2021 about-the-company line |
| Product | Use | Notes |
|---|---|---|
| ROTAVAC / ROTAVAC 5D | Infant rotavirus | WHO-PQ; 5D is the 2-8C presentation |
| Typbar-TCV | Typhoid conjugate | WHO-PQ; company: first tetanus-toxoid conjugated typhoid |
| BIOPOLIO | Oral polio | WHO-PQ |
| JENVAC | Japanese encephalitis | Named on the 2021 about line |
| Chirorab / Indirab | Rabies | Via Chiron Behring acquisition; company: largest rabies-vaccine maker |
| COVAXIN | Inactivated COVID-19 | Historical; DCGI EUA Jan 2021, WHO EUL Nov 2021 |
| Product | WHO PQ date | Indication / presentation |
|---|---|---|
| ROTAVAC | 5 Jan 2018 | Live attenuated rotavirus; frozen liquid, multi-dose vial |
| ROTAVAC 5D | 18 Jun 2021 | Same strain, 2-8C liquid, including single-dose |
| Typbar-TCV | Listed as WHO-PQ on the Jul 2025 WHOPIR | Tetanus-toxoid conjugated typhoid |
| BIOPOLIO B1/3 | Listed as WHO-PQ on the Jul 2025 WHOPIR | Oral polio |
